Cramer Shares His Thoughts On Lockheed Martin Corporation, Celgene Corporation And Regeneron Pharmaceuticals Inc

Loading...
Loading...
Jim Cramer said on
CNBC's Mad Money
that his charitable trust fund had to decrease its position in
Lockheed Martin CorporationLMT
because the stock moved higher and it became a too big part of the portfolio. He added that the stock is in a really good shape for the future. Cramer would not be a seller of
Celgene CorporationCELG
and
Regeneron Pharmaceuticals IncREGN
. He is more inclined to be a buyer.
Market News and Data brought to you by Benzinga APIs
Posted In: CNBCMediaAerospace & DefenseIndustrialsJim CramerMad Money
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...